XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2020 $ 45 $ 433,941 $ 247,638 $ 14,087 $ 695,711
Beginning balance (in shares) at Dec. 31, 2020 44,667,650        
Net income     48,409   48,409
Other comprehensive income (loss)       (3,312) (3,312)
Stock based compensation   1,629     1,629
Cash dividend     (8,050)   (8,050)
Exercise of options   819     819
Exercise of options (in shares) 75,807        
Stock grants - vesting of restricted stock units (in shares) 117,223        
Repurchase of shares from restricted shares vesting   (1,188)     (1,188)
Repurchase of shares from restricted shares vesting (in shares) (40,937)        
Ending balance at Jun. 30, 2021 $ 45 435,201 287,997 10,775 734,018
Ending balance (in shares) at Jun. 30, 2021 44,819,743        
Beginning balance at Mar. 31, 2021 $ 45 434,346 265,970 14,069 714,430
Beginning balance (in shares) at Mar. 31, 2021 44,782,155        
Net income     26,054   26,054
Other comprehensive income (loss)       (3,294) (3,294)
Stock based compensation   634     634
Cash dividend     (4,027)   (4,027)
Exercise of options   465     465
Exercise of options (in shares) 28,807        
Stock grants - vesting of restricted stock units (in shares) 9,138        
Repurchase of shares from restricted shares vesting   (244)     (244)
Repurchase of shares from restricted shares vesting (in shares) (357)        
Ending balance at Jun. 30, 2021 $ 45 435,201 287,997 10,775 734,018
Ending balance (in shares) at Jun. 30, 2021 44,819,743        
Beginning balance at Dec. 31, 2021 $ 56 720,744 340,976 2,275 1,064,051
Beginning balance (in shares) at Dec. 31, 2021 56,432,070        
Net income     64,152   64,152
Other comprehensive income (loss)       (11,348) (11,348)
Stock based compensation   2,037     2,037
Cash dividend     (12,424)   (12,424)
Exercise of options   18     18
Exercise of options (in shares) 2,000        
Stock grants - vesting of restricted stock units (in shares) 133,374        
Repurchase of shares from restricted shares vesting   (1,120)     (1,120)
Repurchase of shares from restricted shares vesting (in shares) (42,947)        
Stock repurchases   (2,457)     (2,457)
Stock repurchases (Shares) (137,583)        
Ending balance at Jun. 30, 2022 $ 56 719,222 392,704 (9,073) 1,102,909
Ending balance (in shares) at Jun. 30, 2022 56,386,914        
Beginning balance at Mar. 31, 2022 $ 57 720,846 365,604 (3,932) 1,082,575
Beginning balance (in shares) at Mar. 31, 2022 56,514,168        
Net income     33,316   33,316
Other comprehensive income (loss)       (5,141) (5,141)
Stock based compensation   833     833
Cash dividend     (6,216)   (6,216)
Stock grants - vesting of restricted stock units $ (1)       (1)
Stock grants - vesting of restricted stock units (in shares) 10,674        
Repurchase of shares from restricted shares vesting (in shares) (345)        
Stock repurchases   (2,457)     (2,457)
Stock repurchases (Shares) (137,583)        
Ending balance at Jun. 30, 2022 $ 56 $ 719,222 $ 392,704 $ (9,073) $ 1,102,909
Ending balance (in shares) at Jun. 30, 2022 56,386,914